Silexion Therapeutics Ltd.

Silexion Therapeutics Ltd.verified

SLXN

Price:

$3.167

Market Cap:

$1.78M

Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. The company was founded in 2008 and is headquartered in Jerusalem,...[Read more]

Industry

Biotechnology

IPO Date

2024-08-16

Stock Exchange

NASDAQ

Ticker

SLXN

The Current Ratio as of December 2025 (TTM) for Silexion Therapeutics Ltd. (SLXN) is 2.44

According to Silexion Therapeutics Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 2.44. This represents a change of 36.29% compared to the average of 1.79 of the last 4 quarters.

Silexion Therapeutics Ltd. (SLXN) Historical Current Ratio (quarterly & annually)

How has SLXN Current Ratio performed in the past?

The mean historical Current Ratio of Silexion Therapeutics Ltd. over the last ten years is 2.26. The current 2.44 Current Ratio has changed 10.65% with respect to the historical average. Over the past ten years (40 quarters), SLXN's Current Ratio was at its highest in in the March 2021 quarter at 13.00. The Current Ratio was at its lowest in in the March 2023 quarter at 0.06.

Quarterly (TTM)
Annual

Average

2.26

Median

1.76

Minimum

0.64

Maximum

5.49

Silexion Therapeutics Ltd. (SLXN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Silexion Therapeutics Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 369.28%

Maximum Annual Current Ratio = 5.49

Minimum Annual Increase = -71.83%

Minimum Annual Current Ratio = 0.64

Quarterly (TTM)
Annual
YearCurrent RatioChange
20240.64-71.83%
20232.27-58.70%
20225.49369.28%
20211.17-33.47%

Silexion Therapeutics Ltd. (SLXN) Average Current Ratio

How has SLXN Current Ratio performed in the past?

The current Current Ratio of Silexion Therapeutics Ltd. (SLXN) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

2.80

5-year avg

2.26

10-year avg

2.26

Silexion Therapeutics Ltd. (SLXN) Current Ratio vs. Peers

How is SLXN’s Current Ratio compared to its peers?

Silexion Therapeutics Ltd.’s Current Ratio is greater than Indaptus Therapeutics, Inc. (0.75), less than Salarius Pharmaceuticals, Inc. (5.49), less than SciSparc Ltd. (5.36), less than Lipella Pharmaceuticals Inc. (3.24), greater than Jasper Therapeutics, Inc. (2.10), greater than Azitra, Inc. (1.23), greater than Protagenic Therapeutics, Inc. (0.29), greater than Onconetix, Inc. (0.08), greater than Scinai Immunotherapeutics Ltd. (0.71), greater than Enveric Biosciences, Inc. (2.43),

Build a custom stock screener for Silexion Therapeutics Ltd. (SLXN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Silexion Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Silexion Therapeutics Ltd. (SLXN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Silexion Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Silexion Therapeutics Ltd.'s Current Ratio?

How is the Current Ratio calculated for Silexion Therapeutics Ltd. (SLXN)?

What is the highest Current Ratio for Silexion Therapeutics Ltd. (SLXN)?

What is the 3-year average Current Ratio for Silexion Therapeutics Ltd. (SLXN)?

What is the 5-year average Current Ratio for Silexion Therapeutics Ltd. (SLXN)?

How does the current Current Ratio for Silexion Therapeutics Ltd. (SLXN) compare to its historical average?